Академический Документы
Профессиональный Документы
Культура Документы
From the research result we found that the average mother age in case group is
29,80±6,90 years old and the average in control group is 28,96±7,32 years old with p = 0,678.
This mean there is no different age in case group and control group.
Average gestational age in case group is 35,96±4,39 weeks and average gestational
age in control group is 36,64±2,87, with p = 0,520. This mean there is no different
gestational age in case group and control group.
Amira El-Messidi dan Alan Cameron, 2010, Diagnosis of Premature Rupture of Membranes:
Inspiration From the Past and Insights for the Future, J Obstet Gynaecol Can
2010;32(6):561–569
Camilla S. Kronborg, Knudsen UB, Sqren K. Moestrup, Allen J, Vittinghus E & Holger J,
Mqller, 2007, Serum markers of macrophage activation in pre-eclampsia: no predictive
value of soluble CD163 and neopterin, Acta Obstetricia et Gynecologica 2007; 86:
1041_1046
Dekker G, Sibai B, dan Kupferminc, 2005, Pre-eclampsia , Lancet 2005; 365: 785–99
Departemen Kesehatan Republik Indonesia (DepKes RI), 2007, Angka Kematian Ibu
Melahirkan , available from https://docs.google.com/viewer?a=v&q=cache:
gSnh5LzvkuQJ:menegpp.go.id/V2/index.php/datadaninformasi/kesehatan?download
%3D23%253Aangka-kematian-ibu-melahirkan-aki+Grafik+Distribusi+ Persentase+
Penyebab+Kematian+Ibu+ Melahirkan accepted 14 August 2012
Dorrith S, Marie L, Padmini K, Godelieve S, Beelen E, Emile, Claas F, Kooten, dan Sicco S,
2011, Differential distribution and phenotype of decidual macrophages in preeclamptic
versus control pregnancies, The American Journal of Pathology 2011;178(2):709-17
Geven WB, Niezen-Koning, A Timmer, AJ Van Loon, RJA Wanders, dan FJ Van Spronsen,
2007, Pre-eclampsia in a woman whose child suffered from lethal carnitine-acylcarnitine
translocase deficiency , BJOG An International Journal of Obstetrics and Gynaecology
2007;114:1028–1030.
Ghulam H.M., 2006, Pregnancy in Women with Kidney Disease, JK- Practitioner 2006; 13
(1):48-51
Grammer, T.B., Fuch D., Boehm, B.O., Winkelmann, B.R., dan Maerz W. 2009. Neopterin as
a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing
Angiography in The Ludwigshafen Risk and Cardiovascular Health Study. Clinical
Chemistry, 55 : 1135–46
Jin Bo Su, 2015. Vascular endothelial dysfunction and pharmacological treatment, World J
Cardiol 2015 November 26; 7(11): 719-741
Luttun A dan Carmeliet P, 2003, Soluble VEGF receptor Flt1: the elusive preeclampsia factor
discovered? Available from http://www.ncbi.nlm.nih.gov /pmc/articles/PMC151908/
accepted 15 August 2013
Ozler A. Turgut A, 2012, Serum Levels of Neopterin, tumor necrosis factor-alpha and
Interleukin-6 in preeclampsia: relationship with disease severity, European Review for
Medical and Pharmacological Sciences 2012; 16: 1707-1712
Page M.N, 2010, Neurokinin B and pre-eclampsia: a decade of discovery available from
http://www.rbej.com/content/8/1/4
Royal College of Obstetricians and Gynaecologists, 2011, Cardiac Disease and Pregnancy
available from https://www.rcog.org.uk/globalassets/documents/
guidelines/goodpractice13cardiacdiseaseandpregnancy.pdf, accepted 26 Mei 2015
The American Diabetes Association’s, 2014, Standar of Medical Care in Diabetes, Journal of
Diabetes Care Volume 37, p.14-80
Valenzuela FJ, Perez-Sepulved A, Torres MJ, Paula Correa, Gabriela M. Repetto, dan
Sebastian E. Illanes, 2012, Pathogenesis of Preeclampsia: The Genetic Component,
Hindawi Publishing Corporation Journal of Pregnancy volume 2012
Yuping W, David F. Lewis, Yang Gu, Yanping Zhang, 2004. Evidence of endothelial
dysfunction in preeclampsia: Decreased endothelial nitric oxide synthase expression is
associated with increased cell permeability in endothelial cells from preeclampsia.,
American Journal of Obstetrics and Gynecology (2004) 190, 817e24